Intrinsic value of Agios Pharmaceuticals, Inc. (AGIO)

Agios Pharmaceuticals, Inc. (AGIO) intrinsic value snapshot: our valuation models currently suggest the stock is undervalued, with an estimated 18.2% upside relative to fair value at a market price of $33.99. Unlock the dollar fair value estimate for Agios Pharmaceuticals, Inc. with Tickerplace Pro.

Intrinsic Value (Fair Value): Unlock fair value

Upside: +18.2%

Margin of Safety: Unlock fair value

Current Price: $33.99

Valuation: Undervalued

Confidence: 5.0/10

Visual Bar

Market Price $33.99Intrinsic Value Locked
Undervalued ✅Fair Value ⚖️Overvalued ❌

How we calculate fair value: We combine DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models to estimate intrinsic value. This figure is for information only - not investment advice - and assumptions may not reflect actual market conditions. We encourage doing your own research or speaking with a financial advisor before making investment decisions.

Intrinsic Value checker

Search our company database (same as the site header), pick a match, or type a ticker to open its intrinsic value analysis.

Is Agios Pharmaceuticals, Inc. (AGIO) undervalued or overvalued?

The verdict and fair-value gap for Agios Pharmaceuticals, Inc. (AGIO) are summarised in the intrinsic value snapshot above. This section explains the method: we compare the live market price with modeled fair value using DCF, P/E Multiple, and P/S Multiple approaches. Assumptions can change with new earnings, growth, and discount-rate inputs, so treat the result as a research aid rather than a buy or sell signal. Tickerplace Pro unlocks the dollar fair value used in that comparison.

Fair value vs market price — Agios Pharmaceuticals, Inc. (AGIO)

Use this section for context around the gap, not a third restatement of the top-line verdict. The free snapshot above already shows the percentage gap and market price; the dollar intrinsic value stays behind Tickerplace Pro. Compare AGIO with related intrinsic-value pages listed below (DNLI, COGT, RCUS, and more) to see how peers are framed on the same models.

Frequently Asked Questions - AGIO

What is the intrinsic value of Agios Pharmaceuticals, Inc. (AGIO)?

Our models calculate the intrinsic value of Agios Pharmaceuticals, Inc. (AGIO) using DCF, P/E Multiple, and P/S Multiple approaches based on projected cash flows, growth rate, and discount rate. Sign in to Tickerplace Pro to view the full dollar estimate.

Is AGIO undervalued or overvalued?

Based on our 2026 valuation models, AGIO appears undervalued at its current price of $33.99. Our model suggests 18.2% upside potential.

How is AGIO's intrinsic value calculated?

Tickerplace calculates AGIO's intrinsic value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We project future cash flows, apply a discount rate that reflects investment risk, and compare the resulting fair value estimate to the current market price.

Related companies — intrinsic value

Peers for AGIO: open their intrinsic value pages.

Explore Our Valuation Calculators